{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:28:34Z","timestamp":1785878914367,"version":"3.56.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,21]],"date-time":"2014-02-21T00:00:00Z","timestamp":1392940800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0089659","type":"journal-article","created":{"date-parts":[[2014,2,21]],"date-time":"2014-02-21T22:26:23Z","timestamp":1393021583000},"page":"e89659","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":90,"title":["In Vitro and In Vivo Activity of a Novel Locked Nucleic Acid (LNA)-Inhibitor-miR-221 against Multiple Myeloma Cells"],"prefix":"10.1371","volume":"9","author":[{"given":"Maria Teresa","family":"Di Martino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Gull\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eugenia","family":"Gallo Cantafio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Altomare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Amodio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santo Giovanni","family":"Lio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Caracciolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels M.","family":"Frandsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierosandro","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfrancesco","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"12885","DOI":"10.1073\/pnas.0806202105","article-title":"MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis","volume":"105","author":"F Pichiorri","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1745-6150-6-23","article-title":"MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival","volume":"6","author":"J Chi","year":"2011","journal-title":"Biol Direct"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Wu P, Agnelli L, Walker BA, Todoerti K, Lionetti M, et al. (2013) Improved risk stratification in myeloma using a microRNA-based classifier. Br J Haematol.","DOI":"10.1111\/bjh.12394"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/leu.2011.147","article-title":"MicroRNA signatures characterize multiple myeloma patients","volume":"25","author":"SL Corthals","year":"2011","journal-title":"Leukemia"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1182\/blood-2009-08-237495","article-title":"Identification of microRNA expression patterns and definition of a microRNA\/mRNA regulatory network in distinct molecular groups of multiple myeloma","volume":"114","author":"M Lionetti","year":"2009","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2174\/156800912802429355","article-title":"Promises and challenges of MicroRNA-based treatment of multiple myeloma","volume":"12","author":"P Tagliaferri","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/PPO.0b013e318258b5d6","article-title":"The therapeutic potential of microRNAs in cancer","volume":"18","author":"SB Thorsen","year":"2012","journal-title":"Cancer J"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Rossi M, Amodio N, Di Martino MT, Caracciolo D, Tagliaferri P, et al. (2013) From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario. Curr Drug Targets.","DOI":"10.2174\/13894501113149990186"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1517\/14712598.2013.807338","article-title":"Emerging pathways as individualized therapeutic target of multiple myeloma","volume":"13","author":"G Misso","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1517\/14712598.2013.796356","article-title":"Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma","volume":"13","author":"N Amodio","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/ejh.12124","article-title":"Aberrant microRNA expression in multiple myeloma","volume":"91","author":"K Dimopoulos","year":"2013","journal-title":"Eur J Haematol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1158\/1078-0432.CCR-12-1708","article-title":"Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence","volume":"18","author":"MT Di Martino","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1038\/cddis.2012.175","article-title":"miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1","volume":"3","author":"N Amodio","year":"2012","journal-title":"Cell Death Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.18632\/oncotarget.675","article-title":"DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma","volume":"3","author":"N Amodio","year":"2012","journal-title":"Oncotarget"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.18632\/oncotarget.820","article-title":"In vitro and in vivo anti-tumor activity of miR-221\/222 inhibitors in multiple myeloma","volume":"4","author":"MT Di Martino","year":"2013","journal-title":"Oncotarget"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1158\/1078-0432.CCR-12-3325","article-title":"Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth","volume":"19","author":"E Leone","year":"2013","journal-title":"Clin Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/onc.2011.280","article-title":"miR-221\/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPmu","volume":"31","author":"C Quintavalle","year":"2012","journal-title":"Oncogene"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1093\/nar\/gkr006","article-title":"NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells","volume":"39","author":"S Galardi","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1476-4598-9-229","article-title":"MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma","volume":"9","author":"CZ Zhang","year":"2010","journal-title":"Mol Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1073\/pnas.0907904107","article-title":"miR-221 overexpression contributes to liver tumorigenesis","volume":"107","author":"P Pineau","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00381-009-1028-y","article-title":"Upregulation of mir-221 and mir-222 in atypical teratoid\/rhabdoid tumors: potential therapeutic targets","volume":"26","author":"ST Sredni","year":"2010","journal-title":"Childs Nerv Syst"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e4029","DOI":"10.1371\/journal.pone.0004029","article-title":"The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice","volume":"3","author":"N Mercatelli","year":"2008","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1158\/0008-5472.CAN-07-2538","article-title":"The promyelocytic leukemia zinc finger-microRNA-221\/\u2212222 pathway controls melanoma progression through multiple oncogenic mechanisms","volume":"68","author":"F Felicetti","year":"2008","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e66502","DOI":"10.1371\/journal.pone.0066502","article-title":"miR-221\/222 Targets Adiponectin Receptor 1 to Promote the Epithelial-to-Mesenchymal Transition in Breast Cancer","volume":"8","author":"MS Hwang","year":"2013","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.3892\/ijo.2013.1879","article-title":"The miR-221\/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma","volume":"42","author":"T Jikuzono","year":"2013","journal-title":"Int J Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nm.2577","article-title":"EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers","volume":"18","author":"M Garofalo","year":"2012","journal-title":"Nat Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ccr.2009.10.014","article-title":"miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation","volume":"16","author":"M Garofalo","year":"2009","journal-title":"Cancer Cell"},{"key":"ref28","first-page":"562","article-title":"Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides","volume":"2","author":"RS Geary","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1126\/science.1189123","article-title":"MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis","volume":"328","author":"SH Najafi-Shoushtari","year":"2010","journal-title":"Science"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1172\/JCI46039","article-title":"A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration","volume":"122","author":"R Ng","year":"2012","journal-title":"J Clin Invest"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1681\/ASN.2011050485","article-title":"Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy","volume":"23","author":"S Putta","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"F793","DOI":"10.1152\/ajprenal.00273.2011","article-title":"Identification of a microRNA signature in renal fibrosis: role of miR-21","volume":"301","author":"A Zarjou","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20100035","article-title":"miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis","volume":"207","author":"G Liu","year":"2010","journal-title":"J Exp Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/CIRCRESAHA.111.255737","article-title":"MicroRNA-29 in aortic dilation: implications for aneurysm formation","volume":"109","author":"RA Boon","year":"2011","journal-title":"Circ Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI61598","article-title":"Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development","volume":"122","author":"L Maegdefessel","year":"2012","journal-title":"J Clin Invest"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1093\/nar\/gkp577","article-title":"Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c\/ebp Beta and down-regulation of G-CSF","volume":"37","author":"J Worm","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.111.030932","article-title":"Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure","volume":"124","author":"RL Montgomery","year":"2011","journal-title":"Circulation"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cell.2012.03.029","article-title":"A cardiac microRNA governs systemic energy homeostasis by regulation of MED13","volume":"149","author":"CE Grueter","year":"2012","journal-title":"Cell"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature11919","article-title":"MicroRNA-34a regulates cardiac ageing and function","volume":"495","author":"RA Boon","year":"2013","journal-title":"Nature"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"HL Janssen","year":"2013","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1158\/1078-0432.CCR-12-2043","article-title":"Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia","volume":"19","author":"M Lionetti","year":"2013","journal-title":"Clin Cancer Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/1535-7163.MCT-08-0149","article-title":"Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cells in vitro and in vivo","volume":"8","author":"R Burger","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1038\/sj.leu.2404912","article-title":"Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma","volume":"21","author":"P Neri","year":"2007","journal-title":"Leukemia"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1158\/1078-0432.CCR-04-2611","article-title":"Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma","volume":"11","author":"P Tassone","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1182\/blood-2005-01-0373","article-title":"A clinically relevant SCID-hu in vivo model of human multiple myeloma","volume":"106","author":"P Tassone","year":"2005","journal-title":"Blood"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2141.2008.07387.x","article-title":"In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor","volume":"143","author":"P Neri","year":"2008","journal-title":"Br J Haematol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"RE Lanford","year":"2010","journal-title":"Science"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0089659","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T13:19:15Z","timestamp":1716556755000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0089659"}},"subtitle":[],"editor":[{"given":"Renato","family":"Franco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,21]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0089659","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,21]]}}}